Toronto Dominion Bank
ASBP

Toronto Dominion Bank’s Aspire Biopharma ASBP Stock Holding History

Toronto Dominion Bank’s Portfolio ASBP Stock Details ASBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$886 Sell
166
-1
-0.6% -$10 ﹤0.01% 2202
2026
Q1 		$5.15K Buy
+167
New +$8.89K ﹤0.01% 1969
2025
Q2 		– Sell
-431
Closed -$350K – 2025
2025
Q1 		$350K Buy
+431
New +$2.98M ﹤0.01% 1197

Other funds holding ASBP

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CA
Crewe Advisors Salt Lake City, Utah $1.38B AUM 41.76% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.73B AUM 42.12% 1-Year Est. Return
CA
Crossingbridge Advisors Pleasantville, New York $567M AUM 0.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Toronto Dominion Bank's ASBP Position: Q2 2026 in Review

Toronto Dominion Bank reduced its Aspire Biopharma (ASBP) stake by 0.6% in Q2 2026, selling an estimated $10 and leaving 166 shares worth $886. The position accounts for ﹤0.01% of the portfolio, ranked #2202.

Toronto Dominion Bank first reported a position in ASBP in Q1 2025 and has held it in 3 quarters since. The position peaked at $350K in Q1 2025. 13 funds tracked by Wall St. Rank hold ASBP as of Q2 2026.

  • Toronto Dominion Bank held 166 shares of Aspire Biopharma worth $886 as of Q2 2026.
  • Toronto Dominion Bank sold 1 Aspire Biopharma share in Q2 2026, an estimated $10.
  • Aspire Biopharma made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #2202 holding.
  • Toronto Dominion Bank first reported a position in Aspire Biopharma in Q1 2025 and has held it in 3 quarters since.
  • Toronto Dominion Bank's Aspire Biopharma position peaked at $350K in Q1 2025.
  • 13 funds tracked by Wall St. Rank held Aspire Biopharma as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.